ANDREA SEAGO: Open Payments
NPI 1831747419 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 34 payments from 15 companies in 2025. Trend: 2023 $21 · 2024 $782 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $257 |
| Novartis Pharmaceuticals Corporation | 8 | $166 |
| SI-BONE, INC. | 6 | $160 |
| Globus Medical, Inc. | 1 | $148 |
| Neurocrine BioSciences, Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $44 |
| Biogen, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Ethicon US, LLC | 1 | $31 |
| ARGENX US, INC. | 1 | $28 |
Products named: WaveWriter Alpha Prime 16, KESIMPTA, Vyrsa V1, INGREZZA, VYEPTI, TYSABRI, HYQVIA, SURGIFLO Hemostatic Matrix.
Industry payments across KY — which companies pay providers there.
